Another Candidate for the Micro-Sample Diagnostics Market; CBC Results in Minutes

The Theranos fiasco (see:The rise and fall of Theranos, the blood-testing startup that went from Silicon Valley darling to facing fraud charges) served to cast a pall over the micro-sample diagnostics market. Now comes news about an Israeli company with a similar strategy but this time with an instrument providing a complete blood count (CBC) and a green light from the FDA (see:Unlike Theranos, startup ’s blood test device ‘delivers on promise’ with FDA nod). Below is an excerpt from the article:Israeli startupSight Diagnostics has received US Food and Drug Administration clearance to market a blood test device that can extract the results of a standard complete blood count test from just a drop of blood in minutes....Sight ’s OLO is a new type of blood analyzer that promises the same accuracy as large laboratory machines but is cost effective and can be used at the point of care, giving physicians the results “in minutes” ....To use Sight ’s product, the physician or nurse pricks the patient’s finger and places a drop of blood into a disposable plastic cartridge that is inserted into the OLO, which looks like a small home printer.The machine, equipped with a camera, takes thousands of images of the millions of cells within the sample. Software developed by the firm based on machine learning algorithms analyzes the images and provides the results in a printout or via email....Recently, Sight also initiated a pharmacy pilot program with major UK chainSupe...
Source: Lab Soft News - Category: Laboratory Medicine Authors: Tags: AI Clinical Lab Testing Diagnostics Food and Drug Administration Healthcare Information Technology Healthcare Innovations Medical Research Point-of-Care Testing Source Type: blogs